IS8105A - Lyfjablanda sem felur í sér ónæmisbæli til að nota í meðhöndlun á húðsjúkdómum - Google Patents

Lyfjablanda sem felur í sér ónæmisbæli til að nota í meðhöndlun á húðsjúkdómum

Info

Publication number
IS8105A
IS8105A IS8105A IS8105A IS8105A IS 8105 A IS8105 A IS 8105A IS 8105 A IS8105 A IS 8105A IS 8105 A IS8105 A IS 8105A IS 8105 A IS8105 A IS 8105A
Authority
IS
Iceland
Prior art keywords
immunosuppressant
treatment
pharmaceutical composition
composition including
skin disorders
Prior art date
Application number
IS8105A
Other languages
English (en)
Inventor
Hirsch Stefan
Karl Mayer Friedrich
Paul Carle
Sekkat Nabila
Weiss Carl-Martin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IS8105A publication Critical patent/IS8105A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS8105A 2003-04-04 2005-10-31 Lyfjablanda sem felur í sér ónæmisbæli til að nota í meðhöndlun á húðsjúkdómum IS8105A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307866.4A GB0307866D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition
PCT/EP2004/003513 WO2004087141A1 (en) 2003-04-04 2004-04-02 Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin diseases

Publications (1)

Publication Number Publication Date
IS8105A true IS8105A (is) 2005-10-31

Family

ID=9956229

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8105A IS8105A (is) 2003-04-04 2005-10-31 Lyfjablanda sem felur í sér ónæmisbæli til að nota í meðhöndlun á húðsjúkdómum

Country Status (13)

Country Link
US (1) US20070276004A1 (is)
EP (1) EP1613314A1 (is)
JP (1) JP2006522059A (is)
CN (1) CN1767826A (is)
AU (1) AU2004226821A1 (is)
BR (1) BRPI0409187A (is)
CA (1) CA2521250A1 (is)
GB (1) GB0307866D0 (is)
IS (1) IS8105A (is)
MX (2) MXPA05010703A (is)
NO (1) NO20055136L (is)
RS (1) RS20050739A (is)
WO (1) WO2004087141A1 (is)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0506139D0 (en) * 2005-03-24 2005-05-04 Transphase Ltd A transdermal topical composition and its uses
CN101578067B (zh) 2005-10-14 2013-07-17 内诺斯蒂姆股份有限公司 无引线心脏起搏器和系统
US9168383B2 (en) 2005-10-14 2015-10-27 Pacesetter, Inc. Leadless cardiac pacemaker with conducted communication
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2016935A1 (en) * 2007-07-09 2009-01-21 Intendis GmbH Pharmaceutical composition for topical application of poorly soluble compounds
WO2010088687A1 (en) 2009-02-02 2010-08-05 Nanostim, Inc. Leadless cardiac pacemaker with secondary fixation capability
WO2012051237A1 (en) 2010-10-12 2012-04-19 Nanostim, Inc. Temperature sensor for a leadless cardiac pacemaker
US9060692B2 (en) 2010-10-12 2015-06-23 Pacesetter, Inc. Temperature sensor for a leadless cardiac pacemaker
WO2012051235A1 (en) 2010-10-13 2012-04-19 Nanostim, Inc. Leadless cardiac pacemaker with anti-unscrewing feature
JP2014501136A (ja) 2010-12-13 2014-01-20 ナノスティム・インコーポレイテッド デリバリーカテーテルシステム及び方法
JP6023720B2 (ja) 2010-12-13 2016-11-09 ナノスティム・インコーポレイテッドＮａｎｏｓｔｉｍ， Ｉｎｃ． ペースメーカーの取出システム及び取出方法
JP2014501584A (ja) 2010-12-20 2014-01-23 ナノスティム・インコーポレイテッド 放射状固定機構を有するリードレスペースメーカー
US20120225952A1 (en) * 2011-03-03 2012-09-06 Warner Kevin S Non-aqueous silicone-based ophthalmic formulations
WO2013067496A2 (en) 2011-11-04 2013-05-10 Nanostim, Inc. Leadless cardiac pacemaker with integral battery and redundant welds
WO2014022661A1 (en) 2012-08-01 2014-02-06 Nanostim, Inc. Biostimulator circuit with flying cell
EP3273938B8 (de) * 2015-03-25 2020-12-23 GCT GmbH Kosmetisches produkt sowie konzentrat zur herstellung des kosmetischen produktes
JP6932180B2 (ja) * 2016-04-04 2021-09-08 エムシー２・セラピューティクス・リミテッドＭＣ２ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ タクロリムスを含む局所組成物
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
MX2024005473A (es) * 2021-12-16 2024-05-22 Procter & Gamble Composicion acondicionadora para el cabello.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08133979A (ja) * 1994-09-16 1996-05-28 Sando Yakuhin Kk 局所適用薬剤組成物
PL184750B1 (pl) * 1994-10-26 2002-12-31 Novartis Ag Kompozycja w postaci emulsji do stosowania miejscowego
GB2327610B (en) * 1994-11-04 1999-06-02 Novartis Ag Macrolide compositions
US6121329A (en) * 1995-12-28 2000-09-19 Yoshitomi Pharmaceutical Industries, Ltd. Topical administration of 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
AU9162498A (en) * 1997-08-18 1999-03-08 Neubourg, Stephanie Foaming skin cream, uses thereof and a method for producing the same
DE69942286D1 (de) * 1998-03-26 2010-06-02 Astellas Pharma Inc Retardpräparat mit Makroliden wie Tacrolimus
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
JP2001064164A (ja) * 1999-06-23 2001-03-13 Health Science Center:Kk 止痒皮膚塗布剤
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
PE20030828A1 (es) * 2002-03-04 2003-11-04 Novartis Ag Composicion oftalmica que comprende ascomicina
GB0218996D0 (en) * 2002-08-14 2002-09-25 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
BRPI0409187A (pt) 2006-04-11
EP1613314A1 (en) 2006-01-11
WO2004087141A1 (en) 2004-10-14
MXPA05010708A (es) 2005-12-12
CA2521250A1 (en) 2004-10-14
GB0307866D0 (en) 2003-05-14
CN1767826A (zh) 2006-05-03
JP2006522059A (ja) 2006-09-28
US20070276004A1 (en) 2007-11-29
MXPA05010703A (es) 2005-12-12
AU2004226821A1 (en) 2004-10-14
RS20050739A (en) 2007-11-15
WO2004087141B1 (en) 2005-01-06
NO20055136L (no) 2006-01-04
NO20055136D0 (no) 2005-11-02

Similar Documents

Publication Publication Date Title
IS8105A (is) Lyfjablanda sem felur í sér ónæmisbæli til að nota í meðhöndlun á húðsjúkdómum
CR8642A (es) Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos
IS7814A (is) Fenetanólamín afleiða í meðhöndlun á öndunarfærasjúkdómum.
EP1727530A4 (en) TOPICAL FORMULATIONS FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS
AU2003286567A8 (en) Methods for the treatment of skin disorders
IL183101A (en) Use of tetrahydrocannabivarin in drug production
IS8142A (is) Læknislyf gagnleg til meðferðar á verkjum
IS7738A (is) Þíasól efnasambönd til notkunar í meðferð á taugahrörnunar truflunum.
HK1073997A1 (en) Administration of agents for the treatment of inflammation
DE60322451D1 (de) 4-Tetrazolyl-4-Phenylpiperidinderivate zur Schmerzbehandlung
IL165394A0 (en) Use of thio-oxindole derivatives in treatment of skin disorders
AU2003228819A8 (en) Combinations for the treatment of inflammatory skin disorders
PL2340872T3 (pl) Nowe preparaty farmaceutyczne użyteczne w leczeniu bezsenności
IS7444A (is) Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum
IS7868A (is) Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
GB2411834B (en) Composition for use in the treatment of dry skin conditions
HK1103006A1 (en) Medical plaster for application on the skin
EP1539100A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISORDERS
GB0310147D0 (en) A composition for use in the treatment of a skin condition in a subject
PT1474415E (pt) Derivados de benzimidazol substituídos em 1-fenilo-2- heteroarilo, o seu uso para a produção de fármacos para o tratamento de doenças imunológicas
IL174968A0 (en) The use of ifenprodil in the treatment of pain
ITVI20030042A1 (it) Dispositivo manuale per trattamento dermatologico ed estetico.
DOP2004000980A (es) [1,8] naftiridin-2- onas y compuestos relacionados para el tratamiento de la esquizofrenia
HK1125634A1 (en) Pharmaceutical for use in the treatment of ureterolithiasis